Списки джерел: "F07C - MALATTIE DELL'APPARATO CARDIOVASCOLARE"

1

Valgimigli, Marco <1972&gt. "Correlazione tra i livelli circolanti di cellule staminali CD34+ e sviluppo di ristesosi binaria in pazienti sottoposti ad angioplastica coronarica con impianto di stent metallico tradizionale: studio prospettico osservazionale." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2007. http://amsdottorato.unibo.it/146/1/Tesi_dottorato_di_ricerca_Marco_Valgimigli.pdf.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Valgimigli, Marco <1972&gt. "Correlazione tra i livelli circolanti di cellule staminali CD34+ e sviluppo di ristesosi binaria in pazienti sottoposti ad angioplastica coronarica con impianto di stent metallico tradizionale: studio prospettico osservazionale." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2007. http://amsdottorato.unibo.it/146/.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Biagini, Elena <1973&gt. "Storia naturale e stratificazione prognostica della cardiomiopatia ipertrofica: nuove acquisizioni." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2007. http://amsdottorato.unibo.it/522/1/biagini.pdf.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Biagini, Elena <1973&gt. "Storia naturale e stratificazione prognostica della cardiomiopatia ipertrofica: nuove acquisizioni." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2007. http://amsdottorato.unibo.it/522/.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Lofiego, Carla <1975&gt. "Il "ritardo evitabile" nella diagnosi di sindrome aortica acuta: analisi dei determinanti clinici e possibili ripercussioni sull'outcome." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2007. http://amsdottorato.unibo.it/523/1/lofiego.pdf.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Lofiego, Carla <1975&gt. "Il "ritardo evitabile" nella diagnosi di sindrome aortica acuta: analisi dei determinanti clinici e possibili ripercussioni sull'outcome." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2007. http://amsdottorato.unibo.it/523/.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Russo, Antonio <1972&gt. "Nuove acquisizioni in termini di insufficienza mitralica: complicanze tromboemboliche dopo chirurgia della valvola mitrale: incidenza, predittori e implicazioni cliniche." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2007. http://amsdottorato.unibo.it/524/1/russo.pdf.

Повний текст джерела

Анотація:

Objectives: to define in patients undergoing surgery for mitral regurgitation (MR) the risk of thrombo-embolic complications, particularly ischemic stroke (IS) compared to that in the general population. Background: MR is frequent, occurs mostly in the elderly and guidelines recommend surgery in asymptomatic patients but IS risks are unknown. Methods: in 1344 patients (65±12 years) consecutively operated for MR (procedures: 897 valve repair, MRep; 447 valve replacement, 231 mechanical, MVRm; 216 biological, MVRb), thrombo-embolic complications particularly IS (diagnosed by a neurologist) during follow-up were assessed early (<30 days), mid-term (30-180 days) and long-term (180 days). Results: IS occurred in 130 patients and IS or transient ischemic attack in 201. IS rates were 1.9±0.4% and 2.7±0.5%, at 30 and 180 days and 8.1±0.8% at 5 years. IS rates were lowest after MRep vs. MVRb and MVRm (6.1±0.9, 8±2.1 and 16.1±2.7% at 5 years, p<0.001). Comparison to IS expected rates in the population showed high risk within 30 days of surgery (Risk-ratio 41[26-60], p<0.001 but p>0.10 between procedures) and moderate risk after 30 days (risk-ratio 1.7 overall, p<0.001; 1.3 for MRep, p=0.07; 0.98 for MVRb, p=0.95; 4.8 for MVRm, p<0.001). Beyond 180 days, IS risk declined further and was not different from the general population for MRep (1.2, p=0.30) and for MVRb (0.9, p=0.72). Risk of IS or transient ischemic attack was higher than the general population in all groups up to 180 days. The risk of bleeding beyond 30 days was lowest in MRep vs. MVRb and MVRm (7±1, 14±4 and 16±3% at 10 years, p<0.001). Conclusion: thrombo-embolic complications after MR surgery are both reason for concern and encouragement. IS risk is notable early, irrespective of the procedure performed, but long-term is not higher than in the general population after MRep and MVRb. Preference for MRep should be emphasized and trials aimed at preventing IS should be conducted to reduce the thrombo-embolic and hemorrhagic risk in patients undergoing surgery for MR.

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Russo, Antonio <1972&gt. "Nuove acquisizioni in termini di insufficienza mitralica: complicanze tromboemboliche dopo chirurgia della valvola mitrale: incidenza, predittori e implicazioni cliniche." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2007. http://amsdottorato.unibo.it/524/.

Повний текст джерела

Анотація:

Objectives: to define in patients undergoing surgery for mitral regurgitation (MR) the risk of thrombo-embolic complications, particularly ischemic stroke (IS) compared to that in the general population. Background: MR is frequent, occurs mostly in the elderly and guidelines recommend surgery in asymptomatic patients but IS risks are unknown. Methods: in 1344 patients (65±12 years) consecutively operated for MR (procedures: 897 valve repair, MRep; 447 valve replacement, 231 mechanical, MVRm; 216 biological, MVRb), thrombo-embolic complications particularly IS (diagnosed by a neurologist) during follow-up were assessed early (<30 days), mid-term (30-180 days) and long-term (180 days). Results: IS occurred in 130 patients and IS or transient ischemic attack in 201. IS rates were 1.9±0.4% and 2.7±0.5%, at 30 and 180 days and 8.1±0.8% at 5 years. IS rates were lowest after MRep vs. MVRb and MVRm (6.1±0.9, 8±2.1 and 16.1±2.7% at 5 years, p<0.001). Comparison to IS expected rates in the population showed high risk within 30 days of surgery (Risk-ratio 41[26-60], p<0.001 but p>0.10 between procedures) and moderate risk after 30 days (risk-ratio 1.7 overall, p<0.001; 1.3 for MRep, p=0.07; 0.98 for MVRb, p=0.95; 4.8 for MVRm, p<0.001). Beyond 180 days, IS risk declined further and was not different from the general population for MRep (1.2, p=0.30) and for MVRb (0.9, p=0.72). Risk of IS or transient ischemic attack was higher than the general population in all groups up to 180 days. The risk of bleeding beyond 30 days was lowest in MRep vs. MVRb and MVRm (7±1, 14±4 and 16±3% at 10 years, p<0.001). Conclusion: thrombo-embolic complications after MR surgery are both reason for concern and encouragement. IS risk is notable early, irrespective of the procedure performed, but long-term is not higher than in the general population after MRep and MVRb. Preference for MRep should be emphasized and trials aimed at preventing IS should be conducted to reduce the thrombo-embolic and hemorrhagic risk in patients undergoing surgery for MR.

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Valzania, Cinzia <1975&gt. "La terapia elettrica di resincronizzazione cardiaca." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2008. http://amsdottorato.unibo.it/838/1/Tesi_Valzania_Cinzia.pdf.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Valzania, Cinzia <1975&gt. "La terapia elettrica di resincronizzazione cardiaca." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2008. http://amsdottorato.unibo.it/838/.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Зміст

Добірка наукової літератури з теми "F07C - MALATTIE DELL'APPARATO CARDIOVASCOLARE"

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Дисертації з теми "F07C - MALATTIE DELL'APPARATO CARDIOVASCOLARE"